Role of toll-like receptor-4 in lung ischemia-reperfusion injury.

Ann Thorac Surg

Department of Surgery, Division of Thoracic Surgery, University of Washington, Seattle, Washington. Electronic address:

Published: April 2015

Background: Toll-like receptor-4 has been implicated in modulating ischemia-reperfusion injury in cardiac, hepatic, renal, and cerebral models. However, its role in lung ischemia-reperfusion injury is unknown. We hypothesize that toll-like receptor-4 has a key role in initiating the inflammatory cascade in lung ischemia-reperfusion injury.

Methods: We used toll-like receptor-4 specific short interference RNA to achieve toll-like receptor-4 knockdown in rats prior to undergoing ischemia and reperfusion. Lungs were explanted and studied for protein expression and markers of lung injury. Additional animals were evaluated for cellular uptake of toll-like receptor-4 short interference RNA. Toll-like receptor-4 short interference RNA localized to the alveolar macrophage.

Results: In animals pretreated with toll-like receptor-4 short interference RNA, toll-like receptor-4 expression and mitogen-activated protein kinase phosphorylation were suppressed. Markers of lung injury including permeability index, myeloperoxidase content, and bronchoalveolar lavage inflammatory cell counts were all reduced with toll-like receptor-4 knockdown.

Conclusions: Toll-like receptor-4 is critical in the development of lung ischemia-reperfusion injury and its activation in the alveolar macrophage may be the initiating step.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.athoracsur.2014.12.062DOI Listing

Publication Analysis

Top Keywords

toll-like receptor-4
44
lung ischemia-reperfusion
16
ischemia-reperfusion injury
16
short interference
16
interference rna
16
receptor-4 short
12
receptor-4
11
toll-like
10
markers lung
8
lung injury
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!